Radboud Institute for Molecular Life Sciences

The Radboud Institute for Molecular Life Sciences is a leading interfaculty research institute of the Faculty of Science that contributes to the research mission of the Radboudumc Research Institute for Medical Innovation. The overarching aim of RIMLS is to decipher the molecular and cellular mechanisms of development and disease.

Also viewed a lot

Highlights

Jop Kind benoemd tot bijzonder hoogleraar Eencellige epigenomica

DNA repair: a look inside the cell’s ‘repair café’

21 November 2024 Research news item

New research from the Group of Jop Kind sheds light on how cells repair damaged DNA. For the first time, the team has mapped the activity of repair proteins in individual human cells.

New insights into DNA organisation during embryonic development

16 September 2024 Research news item

Researchers from the Kind Group have studied the spatial organisation of DNA that is so particular to these early developmental stages. The paper was published in Nature Genetics on 16 September 2024.

Hereditary eye disease treated with investigational gene therapy

Single-cell technology helps researchers advance personalized corneal treatments

28 June 2024 Research news item

Researchers from Radboud University and Tampere University (Finland) have made a significant step forward towards creating effective personalized therapy for corneal damage using Single-cell RNA sequencing.